Nanopatch immunisation against pandemic influenza: improved immune responses at a reduced dose. (2009–2011)

Development of a new way to vaccinate against influenza that will make standard vaccines 100 times more potent than conventional syringe injection. The Nanopatch is made from a silicon wafer, bristling with micro-nanoscale spikes. It painlessly deposits vaccine under the skin surface. Experiments in mice show that even a small vaccine payload delivered to the skin generates good immune responses. The Nanopatch vaccination system is expected to be ready for clinical trials within a few years.
Grant type:
NHMRC Project Grant
Funded by:
National Health and Medical Research Council